A buy-sell agreement is a legally binding contract between physician shareholders that establishes how ownership interests in a medical professional corporation are transferred when a partner dies, becomes disabled, retires, or otherwise exits the practice. For Canadian physicians operating through professional corporations, these agreements are funded most tax-efficiently using corporate-owned life insurance (COLI) — where death benefit proceeds flow tax-free into the Capital Dividend Account (CDA) and can be distributed as tax-free capital dividends to fund the share purchase. Without a properly structured buy-sell agreement, a physician's death or departure can trigger forced practice dissolution, family disputes over share valuation, and significant tax liabilities that could have been avoided entirely.
Provincial medical regulatory bodies across Canada restrict professional corporation share ownership to licensed physicians in good standing. This means a deceased physician's shares cannot simply pass to their spouse or children — creating an urgent need for a predetermined buyout mechanism that protects both the departing physician's family and the continuing practice partners.
At SG Wealth Management, we help physicians structure comprehensive estate and succession plans that integrate buy-sell agreements with corporate insurance strategies, ensuring your practice partnership is protected against every foreseeable triggering event while maximizing tax efficiency through proper CDA utilization.
The two primary buy-sell agreement structures — cross-purchase and redemption (entity purchase) — create fundamentally different tax outcomes for Canadian physicians. Understanding these differences is critical because the wrong structure can cost hundreds of thousands of dollars in unnecessary taxes when shares eventually change hands.
In a cross-purchase agreement, the remaining physician shareholders personally purchase the departing physician's shares. This increases their adjusted cost base (ACB) in the corporation, which reduces future capital gains when they eventually sell their own shares. The higher ACB creates a permanent tax benefit that compounds over time as the practice grows in value.
In a redemption agreement (entity purchase), the professional corporation itself purchases and cancels the departing physician's shares. While administratively simpler — particularly in practices with three or more physicians — redemption triggers deemed dividend treatment under Section 84.1 of the Income Tax Act. Deemed dividends may be taxed at higher marginal rates than capital gains, and the remaining shareholders do not receive an ACB increase.
For physician practices with only two partners, the cross-purchase structure is almost always superior from a tax perspective. For larger group practices with four or more physicians, the administrative complexity of cross-purchase (requiring multiple insurance policies between each pair of physicians) often makes redemption the practical choice — though hybrid structures can sometimes capture the benefits of both approaches.
| Feature | Cross-Purchase | Redemption (Entity Purchase) |
|---|---|---|
| Who buys the shares | Remaining individual shareholders | The corporation itself |
| ACB increase for survivors | Yes — reduces future capital gains | No — ACB remains unchanged |
| Tax treatment for seller | Capital gain (50% inclusion rate) | Deemed dividend (Section 84.1) |
| Insurance policies needed (4 physicians) | 12 policies (each owns 3) | 4 policies (corp owns all) |
| Administrative complexity | High for 3+ partners | Low regardless of partner count |
| CDA utilization | Indirect (requires careful structuring) | Direct — proceeds flow to CDA |
| Best for | 2-physician partnerships | 3+ physician group practices |
The choice between structures should be made in consultation with both your physician-focused financial advisor and a tax lawyer who understands the interaction between Section 84.1, the Capital Dividend Account, and the lifetime capital gains exemption. Getting this wrong at the outset is expensive to correct later — restructuring an existing buy-sell agreement often triggers immediate tax consequences.
Corporate-owned life insurance (COLI) is the most tax-efficient mechanism for funding physician buy-sell agreements in Canada. The strategy leverages the Capital Dividend Account — a notional tax account unique to Canadian private corporations — to create a completely tax-free funding pipeline from premium payment through share purchase.
When a professional corporation owns a life insurance policy on a physician shareholder and is named as beneficiary, the death benefit (minus the policy's adjusted cost basis) is credited to the corporation's CDA upon the physician's death. The corporation can then distribute these CDA funds as tax-free capital dividends to the remaining shareholders, who use the proceeds to purchase the deceased physician's shares from their estate.
The economics are compelling: premiums are paid with corporate after-tax dollars (taxed at the small business rate of approximately 12% on the first $500,000 of active business income), and the proceeds ultimately flow tax-free to fund the buyout. Compare this to personal funding, where premiums would be paid with after-tax personal dollars (at marginal rates of 50%+), making the corporate structure roughly four times more efficient for premium funding.
The type of life insurance for physician buy-sell agreements depends on the physicians' ages and the expected timeline. Term insurance provides the lowest initial premiums but becomes prohibitively expensive after age 65. Permanent insurance (whole life or universal life) builds cash value that can serve as a secondary funding source for disability or retirement buyouts, though premiums are significantly higher initially.
The valuation clause is arguably the most contentious element of any physician buy-sell agreement. A valuation that is too high makes buyouts unaffordable for remaining partners; too low, and the departing physician (or their estate) is unfairly compensated. Canadian medical practices present unique valuation challenges because much of their value is tied to the personal goodwill of individual physicians — patient relationships, referral networks, and surgical skills that cannot be transferred.
Three primary valuation approaches are used for physician practices, each with distinct advantages depending on the practice type and specialty:
Applies a multiplier (typically 1.5x to 4x) to normalized EBITDA or seller's discretionary earnings. The multiple varies by specialty — surgical practices with strong referral bases command higher multiples (3-4x) than walk-in clinics (1-2x). This method works best for established practices with stable, predictable revenue streams and is the most commonly used approach in physician buy-sell agreements.
Corporate surplus strategiesSums tangible assets (medical equipment, leasehold improvements, accounts receivable) plus intangible assets (patient charts, assembled workforce, trade name, non-compete value). This approach is most appropriate for practices where the physical infrastructure and patient base represent the primary value — such as diagnostic imaging centres or multi-physician walk-in clinics where individual physician goodwill is less dominant.
Physician incorporation guideProjects future earnings over a defined period (typically 5-10 years) and discounts to present value using an appropriate discount rate (usually 15-25% for medical practices, reflecting the risk of physician departure). DCF is the most theoretically sound approach but requires significant assumptions about future revenue, making it prone to disagreement. Best used as a secondary validation method alongside earnings multiples.
Physician retirement planningMost well-drafted physician buy-sell agreements use a formula-based approach agreed upon in advance — typically a trailing 3-year average of normalized earnings multiplied by an agreed factor. The formula should be reviewed and updated every 2-3 years (or whenever a significant change occurs, such as adding a new physician partner or acquiring new equipment). Stale valuations are the single most common source of buy-sell agreement disputes in medical practices.
For practices with significant corporate surplus invested in passive portfolios, the valuation must also account for the corporate investment portfolio — which may represent substantial value beyond the practice's operating earnings. This is particularly relevant for physicians who have accumulated years of retained earnings within their professional corporation.
Medical practices face triggering events that do not exist in other business partnerships. Beyond the standard triggers (death, disability, retirement), physician buy-sell agreements must address scenarios unique to medical practice — including loss of hospital privileges, malpractice judgments, regulatory investigations, and changes in billing eligibility that can effectively end a physician's ability to generate revenue.
Death triggers an immediate mandatory buyout, typically funded by the COLI policy proceeds flowing through the CDA. The agreement should specify a timeline (usually 60-90 days) for completing the share transfer and establish interim management provisions for the practice during the transition period.
Total disability is defined as the inability to perform the material duties of the physician's specific medical specialty for a continuous period (typically 90-180 days). Disability buyout insurance provides dedicated funding for this trigger, separate from the physician's personal disability income protection. The waiting period should align with the disability insurance elimination period to prevent gaps.
Loss of medical license — whether through disciplinary action, failure to maintain continuing education requirements, or criminal conviction — should trigger a mandatory sale at a potentially discounted valuation (typically 70-80% of fair market value) to reflect the reputational impact on the remaining practice.
Divorce provisions prevent a physician's ex-spouse from claiming ownership of practice shares through matrimonial property division. While provincial family law varies, the buy-sell agreement should include a "spousal consent" clause where each physician's spouse acknowledges the agreement's terms and waives any claim to direct share ownership.
Each Canadian province has distinct rules governing who may own shares in a medical professional corporation, which directly impacts how buy-sell agreements must be structured. These rules determine whether shares can be held in trust during a transition period, whether family members can hold non-voting shares, and what happens when a physician loses their license or moves to another province.
In Ontario, the Business Corporations Act and the Medicine Act require that all voting shares of a medical professional corporation be owned by the practicing physician. Non-voting shares may be held by family members (spouse, parents, children), but this creates complexity in buy-sell agreements because the non-voting shares must also be addressed in the buyout provisions.
In British Columbia, the Health Professions Act permits only the practicing physician to hold shares in a medical corporation. BC does not allow family member shareholders, simplifying the buy-sell structure but eliminating income-splitting opportunities that exist in other provinces.
In Alberta, the Professional Corporations Regulation under the Health Professions Act allows family members to hold non-voting shares, similar to Ontario. Alberta also permits inter-professional corporations in some circumstances, which can create additional complexity in multi-disciplinary group practices.
These provincial variations mean that a buy-sell agreement drafted for an Ontario medical practice cannot simply be copied for use in British Columbia or Alberta. Each agreement must be tailored to the specific provincial regulatory framework, and physicians who practice in multiple provinces (locum work, telemedicine) face additional complexity in structuring their corporate ownership and buy-sell provisions.
Working with a financial advisor who understands physician-specific planning across provinces ensures your buy-sell agreement complies with your specific regulatory environment while maximizing the available tax planning opportunities within that framework.
While death triggers are straightforward (life insurance proceeds fund the buyout), disability and retirement buyouts present more complex funding challenges. These events are more common than death during active practice years, yet many physician buy-sell agreements inadequately address them — leaving partners exposed to prolonged uncertainty and financial strain.
Disability buyout insurance is a specialized product that provides a lump sum (or structured payments) specifically to fund the purchase of a disabled physician's practice shares. Unlike personal disability income insurance that replaces the physician's earnings, disability buyout insurance is owned by the corporation and pays the corporation (or remaining shareholders) to fund the share purchase. Premiums are typically 2-4% of the coverage amount annually.
The disability definition in the buy-sell agreement must align precisely with the disability buyout insurance policy definition. Misalignment creates dangerous gaps — where the agreement triggers a mandatory buyout but the insurance does not pay, or vice versa. Most physician buy-sell agreements use an "own-occupation" disability definition with a 180-day waiting period before the buyout obligation is triggered.
Retirement buyouts are typically funded through a combination of corporate savings (sinking fund), installment payments over 3-5 years, and potentially the cash value of permanent life insurance policies. The agreement should require 12-24 months advance notice of retirement to allow adequate financial planning and patient transition. Many agreements also include a gradual wind-down provision where the retiring physician reduces their patient load over 6-12 months while the remaining partners absorb the practice volume.
For practices where a retiring physician's personal goodwill represents significant value, the agreement should address whether the retiring physician will provide a non-compete covenant and patient introduction period — and how these obligations affect the buyout valuation. A physician who retires and immediately opens a competing practice nearby has effectively taken their goodwill with them, reducing the value that should be paid for their shares.
A physician's buy-sell agreement does not exist in isolation — it must integrate seamlessly with their broader estate plan, corporate structure, and family wealth transfer strategy. Misalignment between these documents creates gaps that can result in double taxation, unintended beneficiaries, or disputes between the physician's family and their practice partners.
The buy-sell agreement should coordinate with the physician's will to ensure consistent treatment of practice shares. If the will bequeaths "all shares in my professional corporation" to a spouse, but the buy-sell agreement requires those shares to be sold to remaining partners, the two documents conflict. The buy-sell agreement typically takes precedence (as a binding contract between shareholders), but the will should explicitly acknowledge the buy-sell agreement's existence and direct the estate trustee to comply with its terms.
For physicians with significant corporate surplus, the buy-sell agreement valuation must account for both the practice's operating value and the accumulated investment portfolio. Some agreements separate these components — valuing the operating practice on an earnings multiple and the investment portfolio at fair market value — to prevent disputes about whether passive investments should be included in the practice valuation.
The wealth management strategy for each physician partner should also consider the buy-sell agreement's implications. If a physician expects to receive a $2 million buyout upon retirement (funded by installment payments), this represents a significant asset that affects their overall retirement income plan, RRSP and TFSA contribution strategy, and estate distribution.
At SG Wealth Management, we ensure that every element of a physician's financial plan — buy-sell agreement, corporate structure, insurance architecture, investment strategy, and estate plan — works together as a coordinated system rather than a collection of disconnected documents created by different professionals who never communicate.
After reviewing hundreds of physician buy-sell agreements, certain mistakes appear repeatedly — each one creating potential for significant financial harm when a triggering event eventually occurs. These errors are almost always the result of using generic business templates rather than physician-specific agreements drafted by professionals who understand medical practice dynamics.
The agreement was drafted when the practice was worth $500,000 but has never been updated — now the practice is worth $3 million. The departing physician's estate receives a fraction of fair value, or the remaining partners cannot afford the inflated formula price. Review valuations every 2-3 years without exception.
Investment planning for physiciansLife insurance coverage was set at the original practice value and never increased. When a partner dies, the insurance proceeds cover only 40% of the current buyout obligation, forcing remaining partners to finance the shortfall through practice debt or personal borrowing. Coverage should be reviewed annually alongside valuation updates.
Life insurance for physiciansThe agreement addresses death and retirement but has no disability provision. When a partner becomes permanently disabled, the remaining physicians continue paying their share of overhead while receiving no revenue contribution — for years. Disability buyout insurance and clear triggering definitions are essential.
Disability insurance for physiciansThe agreement lacks spousal acknowledgment. During a divorce, the physician's spouse claims 50% of practice shares as matrimonial property, creating an ownership dispute with the remaining partners. All physician shareholders' spouses should sign a consent acknowledging the buy-sell agreement's terms at the outset.
Estate planning for physiciansA four-physician practice uses a cross-purchase structure requiring 12 separate insurance policies with complex premium-sharing arrangements. When one physician becomes uninsurable due to a health condition, the entire funding mechanism fails. Larger practices should use redemption or hybrid structures for administrative simplicity.
Physician incorporation guideThe agreement triggers a redemption without considering Section 84.1 deemed dividend treatment, resulting in the departing physician paying tax at dividend rates rather than capital gains rates. Proper structuring — potentially using a hybrid approach — can save $100,000+ in taxes on a typical physician practice buyout.
Tax planning for physiciansA buy-sell agreement is a legally binding contract between physician shareholders that governs how ownership interests in a medical professional corporation (MPC) are transferred when a triggering event occurs — such as death, disability, retirement, divorce, or loss of medical license. The agreement establishes who can purchase the departing physician's shares, how those shares will be valued, and how the purchase will be funded. For Canadian physicians operating through professional corporations, buy-sell agreements are essential because provincial medical regulatory bodies restrict share ownership to licensed physicians, meaning shares cannot simply be inherited by non-physician family members without proper planning.
The most tax-efficient funding mechanism for physician buy-sell agreements in Canada is corporate-owned life insurance (COLI). When the corporation owns the policy and is named beneficiary, the death benefit is received tax-free and credited to the Capital Dividend Account (CDA). Funds can then be distributed as tax-free capital dividends to remaining shareholders to fund the share purchase. This creates a completely tax-free funding mechanism — the premium payments are made with corporate after-tax dollars (taxed at the small business rate of approximately 12%), and the proceeds flow tax-free through the CDA. Alternative funding methods include sinking funds (corporate savings earmarked for buyout), installment payments over 3-5 years, or bank financing secured against practice assets.
In a cross-purchase agreement, the remaining physician shareholders personally buy the departing physician's shares. In a redemption (entity purchase) agreement, the professional corporation itself purchases and cancels the departing physician's shares. For Canadian physicians, the tax implications differ significantly. Cross-purchase agreements increase the remaining shareholders' adjusted cost base (ACB), reducing future capital gains when they eventually sell. Redemption agreements trigger deemed dividend treatment under Section 84.1, which may be taxed at higher rates than capital gains. However, redemption agreements are simpler to administer in multi-physician practices because only one insurance policy per physician is needed (owned by the corporation), versus multiple cross-ownership policies. A hybrid approach can sometimes capture the benefits of both.
Medical practice valuation for buy-sell agreements typically uses one of three approaches: (1) Multiple of earnings — applying a multiplier (typically 1.5x to 4x) to normalized EBITDA or seller's discretionary earnings, with the multiple varying by specialty, location, and practice characteristics; (2) Asset-based valuation — summing tangible assets (equipment, leasehold improvements) plus intangible assets (patient charts, referral relationships, assembled workforce, trade name); (3) Discounted cash flow — projecting future earnings and discounting to present value. Most physician buy-sell agreements use a formula-based approach (agreed upon in advance) or require independent valuation at the time of triggering event. The formula should be reviewed and updated every 2-3 years to prevent stale valuations that disadvantage either party.
A comprehensive physician buy-sell agreement should address these triggering events: (1) Death — immediate mandatory buyout funded by life insurance; (2) Total disability — typically triggered after 90-180 days of inability to practice, funded by disability buyout insurance; (3) Voluntary retirement — usually requires 6-12 months advance notice with a gradual transition plan; (4) Voluntary withdrawal — leaving the practice for reasons other than retirement, often with different (lower) valuation terms; (5) Loss of medical license — mandatory sale at a potentially discounted valuation; (6) Bankruptcy or creditor action — forced sale to prevent external parties from acquiring practice shares; (7) Divorce — prevents ex-spouse from claiming practice ownership; (8) Expulsion for cause — removal by unanimous vote of remaining partners for defined misconduct. Each trigger should specify its own timeline, valuation method, and payment terms.
Ensure your medical practice is protected against every foreseeable triggering event with a properly structured, tax-efficient buy-sell agreement integrated with your broader financial plan.
Book a Consultation